Developing learning organizations around health data By Romain Finas, Vice President Real-World Evidence, Alira Health Originally published in French by Les Décideurs Magazine. Much has been [...]

It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions. Benjamin Chambon, Alira [...]

Download the Q3 2020 Medical Device Contract Development and Manufacturing M&A Report. Despite the COVID-19 pandemic, M&A activity in the global CDMO industry has been exceptionally [...]

Alira Health’s Vice President, Regulatory, Olga Carroll, Ph.D., has developed a highlights whitepaper on the recent COVID-19 FDA guidance: “Development and Licensure of Vaccines to Prevent [...]

Alira Health is pleased to announce its role as Advisor to Sagard NewGen for the equity investments in Laboratoires Delbert. This recent capital raise of €40m supports the company’s growth [...]

When our client, a leading radiopharmaceutical company, needed support to understand the commercial opportunity represented by a Phase III radiopharmaceutical and its diagnostic radiotracer [...]

The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule this week that would give breakthrough medical devices national Medicare coverage on the same day they receive FDA [...]

Alira Health is proud to announce its role as Strategic Adviser to LEO Pharma in the sale of a portfolio of four pharmaceutical products in the dermatology and nephrology space to Cheplapharm. [...]

Drawing on CDMO and biomedical expertise, Alira Health helped AGC Biologics become one of the few companies offering both plasmid production and cell and gene therapy services. FRAMINGHAM, MA, [...]

BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, announced that Olga Carroll, Ph.D. joined the firm as Vice President of [...]

Alira Health is excited to welcome Romain Finas as our new Vice President, Real-World Evidence. Based in Paris, France, Romain brings deep expertise in real-world data, healthcare workflow [...]

When our client wanted to explore the potential of digital health in the management of chronic respiratory conditions, Alira Health stepped in to help the client fully understand the opportunity. [...]

SIT Laboratorio Farmaceutico a company of DESMA HC Group Acquires LOPRESSOR®, ICAZ® and MIOREL® from Daiichi Sankyo France Paris, Milan – (30 July 2020) Daiichi Sankyo France /(hereafter, [...]

What do clinical trial management and the concept of Dharma have in common? Quite a bit, actually! In this article, Sheryl Kelley, Alira Health’s Associate Director of Data Quality and Finance [...]

  Alira Health is excited to announce our partnership with GCMI, a leading accelerator, and incubator based in Atlanta, Georgia. We look forward to collaborating with GCMI to support their [...]

Clinical Trials Trends: Remote Monitoring By Amy Thorndike, Lead CRA The COVID-19 pandemic caused an urgent need to transition clinical trials from on-site to remote monitoring. Though the [...]

When our client, a biotech company, wanted to understand the potential of their targets, Alira Health helped develop a web-based tool that prioritized targets and provided a decision support [...]

Real-world data, coupled with Alira Health’s lifecycle approach, offers clients deeper insights and patient-centric approaches to drive transformation across healthcare. FRAMINGHAM, MA, USA – [...]

In the past decade, the medical device industry has increasingly leveraged outsourcing partners for many phases of the manufacturing value chain. As the market becomes more global and [...]

When running a clinical trial, it is important to choose the right CRO. This choice impacts the quality and experience of conducting the study. Alira Health’s Manager, Clinical Development, Kenny [...]

Four Critical Factors for Clinical Trial Budget Success By Chris Rao, Vice President, Clinical Development Planning a relevant and accurate budget, regardless of the trial phase or indication, [...]

When our client, a renowned European pharma company, was interested in an in-licensing opportunity to drive its future growth while achieving significant commercial synergies, Alira Health [...]

BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, announces the appointment of Marie-Aude Ohresser to Vice President, [...]

Clinical Trial Guidance for Sponsors: Four Critical Steps for Clinical Trial Success By Chelsea Eckman Chelsea Eckman is the Associate Director of Clinical Operations at Alira Health Clinical. [...]

The Alira Health Regulatory team has worked closely with our industry partners and the FDA during the COVID-19 pandemic, helping to bring critical products to market through the Emergency Use [...]

Alira Health’s Regulatory practice supported the authorization of the emergency use of VentFree™ by FDA under the Emergency Use Authorization. FRAMINGHAM, MASSACHUSETTS – MAY 6, 2020 – Alira [...]

Clinical trials have a number of moving parts that, when working in harmony, can produce a highly successful trial. Members of Alira Health’s Clinical Team, Jen Petrillo, Project Manager, Katrina [...]

Throughout the COVID-19 pandemic, the Alira Health team has worked closely with our partners throughout the healthcare ecosystem to help support the community and get resources into the hands of [...]

BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, welcomes Richard Charter as Vice President, Market Access, MedTech, Europe [...]

COVID-19 and chronic illnesses: Will chronic patients be collateral victims of the epidemic? Carenity, a digital health start-up specializing in medical studies, used their platform to help [...]

The COVID-19 pandemic is having a disruptive effect on every corner of the healthcare industry, but its impact on individual stakeholders varies widely. Differences in exposure to COVID-19 [...]

We have launched a COVID-19 Impact Survey to better understand how organizations across healthcare and life sciences are managing their operation during this crisis. We will make the survey [...]

Click the link below to watch a replay of our recent webinar on the COVID-19 Supply Shortage: Causes, Impact, and Solutions. The COVID-19 crisis has exposed a shortage of critical PPE, equipment, [...]

Clinical trials have been heavily impacted by the COVID-19 crisis, affecting companies in all stages of development. Alira Health’s Christopher Rao, Vice President, Clinical Development, talks [...]

Mark Kasakevich joins Alira Health as Senior Vice President, U.S. Pharma BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, [...]

The novel single-use micro-endoscope with multiple working channels, eliminates the risk of transmitting infections between patients. FRAMINGHAM, Mass., March 31, 2020 /PRNewswire/ — [...]

When our client, a leader in the biopharmaceuticals space, needed support to assess their company’s competitive position and determine areas of growth and focus, the Alira Health team developed [...]

Associate Consultant Dr. Madeleine Zerbato works behind the scenes to solve problems in healthcare. In this post, she offers an insider’s take on emerging healthcare trends and how she helps [...]

With the ongoing impact of COVID-19, I want to address what Alira Health is doing to support our clients, partners, employees, and community. As a global company, we are diligently following all [...]

Alira Health’s Strategy Consulting and Transaction Advisory practices collaborate to help Gener8 grow beyond its core business. MUNICH, GERMANY – MARCH 11, 2020 – Alira Health [...]

Alira Health’s Senior Partner and VP of Medtech, David Uffer, looks at the top medical technology and pharmaceutical trends that we expect to impact the healthcare landscape in 2020. From AI and [...]

When our client, an Asia-based medtech company with a novel POCT solution, wanted to understand the best market access strategy to enter into Latin America, Alira Health shed light on the region [...]

Expanded market access expertise strengthens Alira Health’s suite of healthcare advisory services FRAMINGHAM, MA, USA – December 17, 2019 – Alira Health (www.alirahealth.com), a leading [...]

Alira Health is honored to be named one of Advisory HQs Top 8 Best Healthcare and Medical Consulting Firms in 2019. Advisory HQ’s review and ranking is independently researched and written [...]

Alira Health welcomes Computational Life as new portfolio company for Alira Health Ventures FRAMINGHAM, MASSACHUSETTS – November 20, 2019 – Alira Health (www.alirahealth.com), a leading [...]

Our client, a renowned private equity firm was interested in investing in a fast-growing radiology imaging clinic group. Read on to see how Alira Health performed a thorough commercial due [...]

We are excited to announce that Alira Health has been named a 2019 Top Place to Work by Boston Globe Media in the category of Top Small Employers in Massachusetts. “We are honored to be [...]

Navigation Sciences™ to Present Update on Precision Surgery Technology (iVATS™) for Early Stage Lung Cancer at Innovation Summit San Francisco Conference BROOKLINE, MASSACHUSETTS-  November 14, [...]

Alira Health Welcomes X-COR into Alira Health Ventures as Portfolio Company FRAMINGHAM, MASSACHUSETTS – November 4, 2019 – Alira Health (www.alirahealth.com), a leading international healthcare [...]

When our client, a global manufacturing company, wanted to understand the potential for a healthcare application of their product, they found very little existing data to help determine the [...]

Alira Health announces its role as Buy-side Advisor to Europlant Group on their acquisition of PlantExtrakt Alira Health adds Europlant Group to their growing list of Transaction Advisory [...]

The Artificial Intelligence Medical Imaging market is growing eight times faster than sector average. New technologies will soon allow for the generation of automated outputs, giving physicians [...]

The expanded Acceleration Office Hours program brings a suite of advisory services to support healthcare and life sciences innovators by expanding the top-ranked Massachusetts Life Science [...]

Join the MedTech Bus Tour to visit innovative facilities, from large enterprises to new startups, operating in MetroWest. Plus, enjoy a panel discussion, networking and more.

When our client, a leader in the MedTech space, wanted to understand the available opportunities for new entrants to successfully enter the dialysis market in China, Alira Health used its domain [...]

Alira Health announces its role as Strategic Advisor to Bracco Imaging S.p.A. in the Commercial Due Diligence of Blue Earth Diagnostics. Alira Health adds Bracco Imaging S.p.A to their growing [...]

Alira Health announces new advisory program for healthcare incubators New Acceleration Office Hours program brings a suite of advisory services to help MetroWest’s healthcare and life sciences [...]

Alira Health brought a distinguished group of speakers and panelists together last week discuss the opportunities and challenges for Italian and Spanish firms looking to expand in the U.S., and [...]

When our client, a global leader in immunology, wanted to understand the reason behind inappropriate dosing of their products, the Alira Health Data Science team designed an analytics program to [...]

Alira Health welcomes Paolo Morgese as Vice President, Market Access Paolo will lead the market access activities for Alira Health and manage the new office location in Geneva, Switzerland. [...]

Rescuing a clinical trial: strategies for identifying and correcting issues and ensuring a successful outcome Did you know that 86% of drugs and devices in clinical trials never make it to [...]

The United States is the most important Pharma and Med Device market in the world, worth over $600 billion combined. For many Spanish and Italian healthcare companies, successfully entering the [...]

Assessing Pre-Commercial Value: Refractory Metastatic Colorectal Cancer (mCRC) Monoclonal Antibody Metastatic Colorectal Cancer (mCRC) is the most advanced stage of colorectal cancer and [...]

Alira Health welcomes Joris Pezzini as Partner Former head of business development at UCB will specialize in pharma and biotech innovation.  BOSTON, USA – Alira Health (www.alirahealth.com), a [...]

From Fortune Italia, January 2019. Translated into English from Italian.  The Place to Grow is the World WITH HEADQUARTERS IN BOSTON AND OFFICES IN MILAN, BARCELONA, MUNICH, PARIS, AND SAN [...]

Defining a Niche Market Access Strategy: The U.S. Helicobacter Pylori Urea Breath Test (UBT) Market H. Pylori affects 35% of the U.S. population, including 35 million symptomatic patients. Of [...]

Alira Health welcomes Tom Sommer as Senior Partner MassMEDIC President Emeritus will lead global MedTech business development activities of Alira Health.   BOSTON, USA – JANUARY, 3, 2019 – Alira [...]

Market Snapshot: The Glioblastoma Market (GBM) The GBM Market is growing and is set to increase by 25% by 2024. Read on for Alira Health’s global GBM Market Snapshot. For more information, [...]

New statistical and artificial intelligence capabilities bolster Alira Health’s suite of healthcare advisory services. BOSTON, USA – DECEMBER 17, 2018 – Alira Health, a leading international [...]

We are pleased to announce that David Uffer, Senior Partner at Alira Health, was selected as a speaker for the Early-stage Investment Panel at the 2018 Life Sciences Dealmaking Symposium. Join us [...]

The Alira Health team is eager to meet with you at DeviceTalks Boston 2018. Senior Partners David Uffer and Alan Lucas are available throughout the conference and at Booth #613 in the exhibition [...]

MEET US IN LA JOLLA! The Alira Health team looks forward to seeing you at the Cell & Gene Meeting on the Mesa! Director of Business Development & Strategy Consulting William Hariri, [...]

Paris, France – September 14, 2018 We are proud to announce that Alira Health France has been granted Innovation and Research Provider status as part of The Research Tax Credit (RTC)/Crédit [...]

We are pleased to announce that David Uffer, Partner at Alira Health, was selected to moderate the opening panel on Alternative to the Exit: Start-ups building long-term value at the AdvaMed [...]

Boston, Massachusetts – July 20, 2018 – Alira Health is pleased to announce its role as exclusive financial advisor to Sequel Special Products LLC in the sale to Nissha Co. Ltd. Nissha Co. [...]

Rochester, NY – June 13, 2018 – Alira Health is pleased to announce its role as exclusive strategic and financial advisor to Röchling Group in the acquisition of Precision Medical Products, [...]

  AWARD WINNER ANNOUNCED Krakow, Poland, May 10, 2018 – Alira Health and the European Wound Management Association (EWMA) are pleased to award SastoMed GmbH the 3rd Annual Advanced Wound [...]

Padova, Italy – May 14, 2018 – Alira Health is pleased to announce its role as exclusive financial advisor to M31 Italia and Adaptica with the sale of Adaptica to an unnamed Chinese eye [...]

Wednesday, June 6, 2018 5:00 PM – 8:00 PM (EST) John Joseph Moakley United States Courthouse 1 Courthouse Way Boston, MA 02210 REGISTER HERE  KICK OFF YOUR SHOES AND JOIN US FOR [...]

  Alira Health is pleased to announce its sponsorship of the 17th annual MIXiii-BIOMED 2018 Conference and Exhibition in Tel Aviv. Are you looking for a better approach to regulatory and [...]

MEET WITH US! Alira Health is pleased to announce its sponsorship of the World Advanced Therapies & Regenerative Medicine Congress 2018 in London. Dr. Martin Pöhlchen, Partner, and William [...]

The 3rd Annual Alira Health – EWMA Advanced Wound Care Innovation Symposium is one of the key events during the upcoming 2018 EWMA Congress. New wound healing innovations will be presented [...]

Read more at: www.forbes.com/best-management-consulting-firms/list/

REAL WORLD EVIDENCE The Importance and Impact on MedTech Market Access Alira Health is pleased to announce its sponsorship of the 22nd Annual MassMEDIC Conference in Boston. Gabriele [...]

WOUND CARE INNOVATORS WANTED!  Alira Health and EWMA invite innovators in advanced wound care to submit applications to present their technologies at the 3rd Annual Advanced Wound Care [...]

Alira Health is pleased to announce sponsorship, participation and attendance at the MedTech Strategist Innovation Summit in Dublin this year. David Uffer, Senior Partner, Piergiulio Lauriano, [...]

The impact and future of digitization along the value chain of the pharmaceutical industry Read [...]

The Association of the Pharmaceutical Industry in Germany (BPI – Bundesverband der Pharmazeutischen Industrie e.V. ) selected Alira Health its exclusive partner for their one-day workshop [...]

Munich, Germany – March 19, 2018 – Fidelio Healthcare, a Germany – based Consultancy Services company for the Healthcare industry, acquired Mundipharma’s manufacturing facilities located in [...]

Digital Transformation in Healthcare and Pharma Thursday, March 22, 2018 10:30 – 11:00 AM CET Future Health Ausstellung EG. STAGEX BIOTECH & NEWPHARMA Dr. Martin Pöhlchen, Partner, [...]

Read More on Outsourcing Pharma: Alira Health acquires MA-based CRO as it expands services, global footprint

Framingham, MA – February 20, 2018 – Alira Health, an international healthcare and life science advisory firm, announced that it has acquired Clinical Assistance Programs (CAP), a contract [...]

Rating Summary Alira Health stands out as one of the best healthcare consulting firms for their dedication to expert advisement in the life sciences and healthcare industries, employing an [...]

Alira Health, Burns & Levinson LLP, BDO USA, LLP, and Woodruff-Sawyer & Co. invite you to a complimentary networking reception. Greet old friends, share a toast with colleagues, and make [...]

AdvaMed’s Events and Education covers the regulatory, reimbursement, legal & compliance, and sales & marketing industry environments. AdvaMed offers both members and nonmembers an [...]

M&A Outlook: 2017 Trends and Predictions for 2018 We are pleased to announce that Gabriele Brambilla, CEO of Alira Health, was selected as a panelist for the M&A Outlook panel at [...]

Paris, France – August 1, 2017-Innovus Pharma announced the signing of an exclusive license and distribution agreement with Densmore Pharmaceutical International for the commercialization [...]

Alira Health Advises Polylinks in Sale to Enplas July 27, 2017 San Francisco, California – July 27, 2017–Enplas, a Japanese public company, acquired Polylinks, a specialized contract [...]

To give children the opportunity to get in touch with nature and exercise, Alira Health partnered with SMOC and Town of Framingham Parks and Recreation to hold the first Summer Soccer Clinic. The [...]

Martin Pöhlchen, PhD, Partner at Alira Health, Germany, will discuss the challenges and opportunities of digital transformation in healthcare at the DVFA Life Science Conference in Frankfurt am [...]

Alira Health and EWMA held their second annual Wound Care Innovation Symposium on May 4th in Amsterdam, The Netherlands. Among the presenting finalists, Dr. Bernke Papenburg, COO of Materiomics [...]

Alira Health and EWMA are holding the 2nd Annual Wound Care Innovation Symposium during this year’s EWMA Conference in Amsterdam, Netherlands on May 4th from 3-7pm. The symposium features [...]

Alira Health’s Pharma Practice includes strategists, health economists, doctors and pharmacists to support pharmaceutical and biotechnology companies in planning and executing successful [...]

Benjamin Chambon, Chief Operating Officer of Alira Health, and William Hariri, Director, Business Development and  Strategy Consulting, will be attending Biovision.  We have decades of experience [...]

FIND YOUR NEXT OPPORTUNITY WITH ALIRA HEALTH Alira Health’s experts would like to meet with you at BIO-Europe Spring. Whether it is commercial strategy development, health economics, [...]

Boston, MA – Alira Health is pleased to announce that Mary McNamara-Cullinane, RAC has joined the firm as a Partner, bringing her extensive expertise in Regulatory Consulting to Alira [...]

Alira Health is pleased to announce that David Uffer has joined the firm as a Partner, bringing his extensive expertise in business strategy, transaction services, and strategy execution to Alira [...]

Health Economics of measuring High-sensitive Cardiac Troponin at different Cut-offs in Non ST Segment Elevation Myocardial Infarction Patients with-in 6 Hours from Emergency Room Presentation [...]

Despite the fairly stable number of asset deals per year, their accumulated value significantly increased from 2010 and 2015, showing positive momentum for this type of transaction. Importantly, [...]

Alira Health is pleased to announce their team’s attendance at HIMSS 17. The 2017 HIMSS Annual Conference & Exhibition brings together 40,000+ health IT professionals, clinicians, [...]

  Alira Health advised Ipsen in the Acquisition of Akkadeas Pharma February 6, 2017 Paris, France – February 6, 2017 – Ipsen announced that it has signed an agreement to take an [...]

New name reflects dramatic expansion to include innovative research, product development, and business incubator Our New Identity Boston, USA and Paris, France — January 9, 2017 CMC Consulting [...]

CMC Consulting Group (www.cmc-co.net) is pleased to announce its new name, Alira Health, effective January 1, 2017. The company’s decision reflects the continuing evolution of its advisory, [...]

Boston, Massachusetts — CMC Consulting Group, an international healthcare advisory firm, has announced its Medical Affairs Division’s (MAD) one-year anniversary. Since their October 2014 [...]

CMC Advised MNH in the Acquisition of Groupe Profession Santé September 5, 2016 Paris, September 5, 2016 – Mutuelle Nationale des Hospitaliers (MNH) acquired the majority stake in Groupe [...]

(Cambridge, MA) Gabriele Brambilla, CEO of CMC Consulting Group, was the keynote speaker for the closing reception at the Harvard vs MIT Case Competition. In his speech, he gave a panoramic view [...]

TCP Reliable purchased the assets of LaunchWorks Manufacturing Lab, an ISO 13485 certified contract manufacturing organization and provider of supply chain solutions.  Prior to the transaction, [...]

BREMEN, GERMANY – CMC and EWMA held their first annual Wound Care Innovation Symposium on May 12th in Bremen, Germany. Among the presenting finalists, Imbed Biosciences Inc. was awarded the [...]

  CMC Advises Mitim Srl in the Sale to Recipharm February 25, 2016   Milan – Recipharm AB today announces that it has entered into an agreement to acquire Italian CDMO, Mitim Srl [...]

Milan – Eukedos S.p.A. and Augens Capital announce the signature of a definitive agreement for Augeo 1 S.r.l., an investment vehicle affiliated with Augens Capital, to acquire Delta Med S.p.A. [...]

The afternoon long conference brought together over 90 leaders in healthcare innovation including clinical experts, distinguished academics, financial investors, and corporates who discussed the [...]

CMC Advises Keosys on sale of a majority stake to JMC Investment September 15, 2015 Paris, France –  CMC congratulates its client, Keosys on the sale of a majority stake of the company to [...]

CMC Advises Lavorel Medicare in the Acquisition of LDTAS Apotecnia April 14, 2015 Paris, France – Lavorel Groupe announced the acquisition of LTDAS Apotecnia through their subsidiary [...]

CMC Advises Sidam on Sale to Synopo March 3, 2015 Milan, Italy – CMC congratulates its client, Sidam S.r.l.  on the sale of the company to Synopo S.p.A.  Founded in 1991, Sidam manufactures [...]

  CMC Transaction Services Advises Idex Corporation on Acquisition of CiDRA Precision Services February 8, 2015 Boston, MA – CMC Transaction Services, the life science focused investment bank, [...]

CMC Advises CutisPharma on Equity Financing January 15, 2015 Boston, MA – Johnston Blakely & Company, a CMC Group company, congratulates its client, CutisPharma, Inc., on its [...]

Developing learning organizations around health data By Romain Finas, Vice President Real-World Evidence, Alira Health Originally published in French by Les Décideurs Magazine. Much has been [...]

It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions. Benjamin Chambon, Alira [...]

Download the Q3 2020 Medical Device Contract Development and Manufacturing M&A Report. Despite the COVID-19 pandemic, M&A activity in the global CDMO industry has been exceptionally [...]

Alira Health’s Vice President, Regulatory, Olga Carroll, Ph.D., has developed a highlights whitepaper on the recent COVID-19 FDA guidance: “Development and Licensure of Vaccines to Prevent [...]

Alira Health is pleased to announce its role as Advisor to Sagard NewGen for the equity investments in Laboratoires Delbert. This recent capital raise of €40m supports the company’s growth [...]

When our client, a leading radiopharmaceutical company, needed support to understand the commercial opportunity represented by a Phase III radiopharmaceutical and its diagnostic radiotracer [...]

The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule this week that would give breakthrough medical devices national Medicare coverage on the same day they receive FDA [...]

Alira Health is proud to announce its role as Strategic Adviser to LEO Pharma in the sale of a portfolio of four pharmaceutical products in the dermatology and nephrology space to Cheplapharm. [...]

Drawing on CDMO and biomedical expertise, Alira Health helped AGC Biologics become one of the few companies offering both plasmid production and cell and gene therapy services. FRAMINGHAM, MA, [...]

BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, announced that Olga Carroll, Ph.D. joined the firm as Vice President of [...]

Alira Health is excited to welcome Romain Finas as our new Vice President, Real-World Evidence. Based in Paris, France, Romain brings deep expertise in real-world data, healthcare workflow [...]

When our client wanted to explore the potential of digital health in the management of chronic respiratory conditions, Alira Health stepped in to help the client fully understand the opportunity. [...]

SIT Laboratorio Farmaceutico a company of DESMA HC Group Acquires LOPRESSOR®, ICAZ® and MIOREL® from Daiichi Sankyo France Paris, Milan – (30 July 2020) Daiichi Sankyo France /(hereafter, [...]

What do clinical trial management and the concept of Dharma have in common? Quite a bit, actually! In this article, Sheryl Kelley, Alira Health’s Associate Director of Data Quality and Finance [...]

  Alira Health is excited to announce our partnership with GCMI, a leading accelerator, and incubator based in Atlanta, Georgia. We look forward to collaborating with GCMI to support their [...]

Clinical Trials Trends: Remote Monitoring By Amy Thorndike, Lead CRA The COVID-19 pandemic caused an urgent need to transition clinical trials from on-site to remote monitoring. Though the [...]

When our client, a biotech company, wanted to understand the potential of their targets, Alira Health helped develop a web-based tool that prioritized targets and provided a decision support [...]

Real-world data, coupled with Alira Health’s lifecycle approach, offers clients deeper insights and patient-centric approaches to drive transformation across healthcare. FRAMINGHAM, MA, USA – [...]

In the past decade, the medical device industry has increasingly leveraged outsourcing partners for many phases of the manufacturing value chain. As the market becomes more global and [...]

When running a clinical trial, it is important to choose the right CRO. This choice impacts the quality and experience of conducting the study. Alira Health’s Manager, Clinical Development, Kenny [...]